Mylan is one of the world’s leading global pharmaceutical companies. With a global workforce of more than 30 000 people, we have a global market portfolio of more than 1400 separate products in approximately 165 countries and territories. Our medicines include generic and brand name products in a variety of dosage forms and therapeutic categories, such as difficult-to-manufacture injectables, transdermal patches and HIV/AIDS antiretroviral (ARV) therapies. The company has innovative research and development capabilities and is one of the world’s largest active pharmaceutical ingredient (API) manufacturers. Every one of our medications meets our one global quality standard regardless of where it is produced. At Mylan, we are committed to setting new standards in healthcare, working together around the world to provide 7 billion people access to high quality medicine. Nearly 50% of people living with HIV/AIDS in the developing world who are receiving treatment depend on a Mylan product. Creating better health for a better world is what inspires Mylan in our mission to provide quality healthcare to the world’s 7 billion people, one person at a time.